Restriction Fragment Length Polymorphism

Restriction fragment length polymorphism (RFLP) is a molecular marker technique based on the length polymorphism of DNA fragments. It was proposed by Botstein et al. (1980) to construct human genetic maps by using restriction enzymes to cut DNA samples and then separating and detecting the different lengths of DNA fragments by gel electrophoresis and hybridization probes. RFLP has several advantages, such as high specificity, genetic stability, and rich polymorphism, but it also has some drawbacks, such as complex operation, poor repeatability, and being limited by the types and numbers of restriction enzymes and sites.

How restriction fragment length polymorphism (RFLP) worksFig.1 How restriction fragment length polymorphism (RFLP) works

RFLP can be used to detect the causes of genetic diseases, such as gene mutations, deletions, insertions, rearrangements, etc. It can also be used to diagnose some common genetic diseases, such as β-thalassemia, congenital adrenal hyperplasia, Huntington's disease, ovarian cancer, and so on. RFLP has some merits and limitations in genetic disease diagnosis, such as sensitivity, specificity, accuracy, and cost-effectiveness. RFLP can also be used for genetic map construction and gene localization, by analyzing the linkage relationship between RFLP markers and target genes or traits in different individuals or populations, and determining the position and order of target genes or traits on chromosomes. Moreover, RFLP can be used for kinship identification and paternity testing, by comparing the consistency or difference of RFLP markers among different individuals or populations, and inferring their kinship or paternity. Furthermore, RFLP can be used for species identification and evolutionary analysis, by comparing the diversity or homology of RFLP markers among different species or populations, and judging their taxonomic or evolutionary relationships.

Role of RFLPs as Markers for the Identification of Genetic Disorders

Genetic diseases are disorders caused by abnormalities in the genes or chromosomes of an individual. They can be inherited from parents or acquired due to mutations or environmental factors. The diagnosis and treatment of genetic diseases require the identification of the causative genes or mutations that are responsible for the disease phenotype. However, this is not always easy or feasible, especially for complex or rare diseases that involve multiple genes or unknown mechanisms. Therefore, molecular markers that can indicate the presence or absence of a gene or mutation are useful tools for genetic disease analysis.

RFLPs are one type of molecular marker that can be used to identify genetic diseases. RFLPs are variations in the DNA sequences that alter the recognition sites of restriction enzymes, which are enzymes that cut DNA at specific sequences. As a result, different individuals or populations may have different lengths of DNA fragments after digestion with the same restriction enzyme. These fragments can be separated by gel electrophoresis and detected by hybridization with specific probes.

RFLPs can be used to detect the causes of genetic diseases, such as gene mutations, deletions, insertions, and rearrangements. For example, RFLPs can be used to diagnose β-thalassemia, a blood disorder caused by mutations in the β-globin gene that reduce or abolish its expression. By digesting the DNA samples with restriction enzymes and probing with β-globin gene fragments, different RFLP patterns can be observed for normal, heterozygous carrier, and homozygous affected individuals.

RFLPs can also be used to diagnose some common genetic diseases, such as congenital adrenal hyperplasia (CAH), Huntington's disease (HD), and ovarian cancer. CAH is a disorder caused by mutations in the 21-hydroxylase gene that impair the synthesis of cortisol and aldosterone. By digesting the DNA samples with restriction enzymes and probing with 21-hydroxylase gene fragments, different RFLP patterns can be observed for normal and affected individuals. HD is a neurodegenerative disorder caused by an expansion of CAG repeats in the huntingtin gene. By digesting the DNA samples with restriction enzymes and probing with huntingtin gene fragments, different RFLP patterns can be observed for normal and affected individuals. Ovarian cancer is a malignancy that can be associated with mutations in the BRCA1 and BRCA2 genes. By digesting the DNA samples with restriction enzymes and probing with BRCA1 and BRCA2 gene fragments, different RFLP patterns can be observed for normal and affected individuals.

RFLPs have some advantages and limitations in genetic disease diagnosis. Some advantages are high specificity, genetic stability, and rich polymorphism. RFLPs can distinguish between different alleles or mutations at a single locus with high accuracy and reliability. RFLPs are also stable and inherited according to Mendelian laws, which makes them suitable for linkage analysis and family studies. RFLPs are also abundant and widely distributed in the genome, which increases their chances of being linked to disease genes or traits.

Some limitations are complex operations, poor repeatability, and restriction enzymes and sites. RFLPs require large amounts of high-quality DNA samples, which may not always be available or easy to obtain. RFLPs also involve multiple steps of digestion, electrophoresis, transfer, hybridization, and detection, which may introduce errors or variations in the results. RFLPs are also dependent on the availability and suitability of restriction enzymes and probes for a given locus or mutation, which may not always be optimal or sufficient.

RFLP Procedure

RFLP is a molecular marker technique that involves several steps of DNA digestion, electrophoresis, transfer, hybridization, and detection. The general procedure for RFLP is as follows:

  1. DNA extraction: The first step is to isolate and purify the DNA from the sample of interest, such as blood, saliva, hair, etc. The quality and quantity of the DNA are important for the subsequent steps of RFLP analysis.
  2. DNA fragmentation: The second step is to digest the DNA with restriction enzymes, which are enzymes that recognize and cut specific sequences of DNA. Different restriction enzymes have different recognition sites and produce different lengths of DNA fragments. The choice of restriction enzymes depends on the locus or mutation of interest and the availability and suitability of probes.
  3. Gel electrophoresis: The third step is to separate the DNA fragments by gel electrophoresis, which is a technique that uses an electric field to move the negatively charged DNA molecules through a porous gel matrix. The smaller fragments move faster and farther than the larger ones, resulting in a pattern of bands on the gel. The gel can be stained with dyes such as ethidium bromide to visualize the bands under UV light.
  4. Transfer: The fourth step is to transfer the DNA fragments from the gel to a membrane, such as nylon or nitrocellulose, by a process called blotting. This is done by placing the gel on top of the membrane and applying pressure or electric current to transfer the DNA molecules to the membrane. The membrane is then baked or cross-linked to fix the DNA fragments on its surface.
  5. Hybridization: The fifth step is to hybridize the membrane with probes, which are labeled DNA sequences that are complementary to the target sequences of interest. The probes can be labeled with radioactive isotopes, fluorescent dyes, or enzymes that produce color signals. The probes bind to their matching sequences on the membrane by base pairing, forming double-stranded DNA molecules.
  6. Detection: The final step is to detect the hybridized probes on the membrane by using autoradiography, fluorescence microscopy, or colorimetric methods. The hybridized probes reveal the presence or absence of specific DNA fragments on the membrane, corresponding to different genotypes or mutations at a given locus.

Applications of RFLP

RFLP has wide and important applications in various fields of biology, such as genetic disease diagnosis and treatment, genetic map construction and gene localization, kinship identification and paternity testing, species identification and evolutionary analysis. For example, RFLP can be used to construct genetic maps and locate genes or traits on chromosomes by analyzing the linkage relationship between RFLP markers and target genes or traits in different individuals or populations. For example, RFLP can be used to map the human genome by using restriction enzymes and probes that target specific regions of DNA that are known to vary among individuals. By comparing the RFLP patterns of different individuals, the relative position and distance of the markers and genes on the chromosomes can be determined. RFLP can also be used to identify quantitative trait loci (QTLs), which are regions of DNA that influence quantitative traits such as height, weight, blood pressure, and so on. Also, RFLP can be used to identify the kinship or paternity of individuals or populations by comparing the similarity or difference of RFLP markers among them. For example, RFLP can be used to determine the biological father of a child by comparing the RFLP patterns of the child, the mother, and the alleged father. If the child inherits one allele from each parent at a given locus, then the RFLP pattern of the child should match one band from each parent at that locus. RFLP can also be used to trace ancestry or genealogy by comparing the RFLP patterns of individuals or populations with known historical or geographical origins. Moreover, RFLP can be used to identify species or populations by comparing the diversity or homology of RFLP markers among them. For example, RFLP can be used to distinguish between different species or strains of bacteria by using restriction enzymes and probes that target specific regions of DNA that are unique or conserved among them. By analyzing the RFLP patterns of different bacterial samples, their taxonomic classification or phylogenetic relationship can be inferred. RFLP can also be used to study the evolution and migration of wildlife by comparing the RFLP patterns of different species or populations with known evolutionary histories or geographical distributions.

References

  1. Zhang Y, et al. Highly efficient genome editing in plant protoplasts by ribonucleoprotein delivery of CRISPR-Cas12a nucleases. Front Genome Ed. 2022;4:780238.
  2. Amiteye S, et al. Basic concepts and methodologies of DNA marker systems in plant molecular breeding. Heliyon. 2021;7(10):e08093.
  3. Khan S, et al. Restriction fragment length polymorphism (RFLP) analysis: a technique for molecular diagnosis of genetic diseases. J Mol Biomark Diagn. 2017;8(5):1-4.
  4. Konzen ER, et al. Molecular markers: a tool for genetic diversity analysis in plants and animals. Int J Curr Microbiol App Sci. 2017;6(11):1-16.
  5. Wang Y, et al. Development of a novel RFLP assay for genotyping the bovine kappa-casein gene and its association with milk production traits in Chinese Holstein cattle. Anim Biotechnol. 2018;29(3):191-197.
  6. Liu Y, et al. Development of a PCR-RFLP method for identification of three species of Macrobrachium (Decapoda: Palaemonidae) based on mitochondrial COI gene sequences. Mitochondrial DNA Part A. 2017;28(6):853-856.
  7. Li X, et al. Development and application of a PCR-RFLP method based on the rpoB gene to differentiate Candida parapsilosis sensu lato species. BMC Infect Dis. 2018;18(1):1-6.
  8. Wang X, et al. Development and validation of a PCR-RFLP assay for rapid identification of four common Candida species isolated from blood cultures in China. BMC Infect Dis. 2019;19(1):1-8.
  9. Wang L, et al. Development and application of a PCR-RFLP method for rapid identification of Fusarium oxysporum f.sp cubense race 4 based on the SNPs in the IGS region of rDNA. J Phytopathol. 2019;167(11-12):667-674.
For research use only. Not intended for any clinical use.